Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Staphylococcus Aureus
89%
Penicillinase
75%
Antiinfective Agent
63%
Antibacterial Activity
52%
Clostridium Difficile Infection
47%
Mouse
46%
Antibiotic Agent
42%
Structure Activity Relationship
41%
Vancomycin
39%
Meticillin
37%
Pseudomonas aeruginosa
33%
Rabbit Model
31%
Infectious Agent
31%
Glycopeptide
31%
Carbapenem
30%
Drug Development
29%
Lantibiotic
28%
Glycylcycline Derivative
28%
Escherichia coli
27%
Imipenem
22%
Antibiotics
21%
Alpha Toxin
21%
Serine
20%
Meropenem
18%
Piperacillin
18%
Prodrug
18%
Combination Therapy
16%
Klebsiella pneumoniae
16%
Enterobacteriaceae
16%
Bacterial Infection
15%
Carbapenemase
15%
Imidazole
15%
Carbapenem Derivative
15%
Gram Negative Bacterium
15%
Streptococcus Pneumoniae
14%
Linezolid
14%
Experimental Infection
14%
Thiazepine
14%
Tigecycline
14%
Polypeptide Antibiotic Agent
14%
Vancomycin-Resistant Enterococcus
14%
Staphylococcal Infection
14%
Pharmacokinetics
13%
Hamster Model
12%
Disease
11%
Peptoclostridium difficile
11%
Pseudomonas
11%
Streptococcus
11%
Tobramycin
11%
Keyphrases
Staphylococcus Aureus
73%
Clostridium Difficile Infection
59%
β-lactamase Inhibitor
59%
β-lactamase
50%
In Vivo Activity
45%
Vancomycin
43%
Aminomethyl
43%
In Vitro Activity
37%
Penem
36%
Methylidene
35%
Structure-activity Relationship
34%
Mannopeptimycin
33%
Pseudomonas Aeruginosa (P. aeruginosa)
32%
Rabbit Model
32%
Antibiotics
29%
Lantibiotics
28%
Glycylcycline
28%
Imipenem
27%
Glycopeptides
27%
In Vivo Efficacy
25%
Carbapenems
25%
Hamster
24%
Pneumonia
23%
Meropenem
23%
Antibacterial Activity
23%
Difficile
23%
Antimicrobial Activity
23%
Murine Model
22%
Prodrug
22%
Alpha-toxin
21%
Preclinical Development
21%
Piperacillin
20%
Infection Model
19%
Escherichia Coli
19%
Methicillin-resistant S. Aureus
18%
Metallo-β-lactamase
18%
Gram-negative Bacteria
18%
Oral Function
17%
Lung
17%
β-lactam Antibiotics
17%
Klebsiella Pneumoniae (K. pneumoniae)
16%
Hamster Model
16%
Imidazole
16%
Streptococcus Pneumoniae
16%
Pathogen-specific
15%
In Vitro Antibacterial Activity
15%
Immunoglobulin
15%
Specific Immunoglobulins
15%
Experimental Infection Model
14%
Semi-synthetic
14%
Immunology and Microbiology
Staphylococcus Aureus
67%
Mouse
40%
Infectious Agent
36%
Minimum Inhibitory Concentration
36%
Peptoclostridium difficile
28%
Klebsiella pneumoniae
20%
Hamster Model
19%
Immunoglobulin A
19%
Colony-Forming Unit
19%
Colony Forming Unit S
19%
Body Weight
17%
Human Respiratory Syncytial Virus
14%
MIC90
14%
Antibacterial Activity
14%
Lantibiotic
14%
Mouse Model
14%
Gene Expression
14%
Secretion (Process)
14%
Escherichia coli
12%
Gram-Negative Bacteria
12%
Endocarditis
12%
Pharmacokinetics
11%
Methicillin-Resistant Staphylococcus Aureus
11%
Enterobacteriaceae
10%
Pyelonephritis
10%
Fatty Acid Synthesis
10%
Blood Plasma
9%
Wild Type
9%
Neutralization
8%
Chlorocebus Aethiops
8%
Pseudomonas
8%
Monoclonal Antibody
8%
Rabbit Model
8%
Antitoxin
8%
Titer
7%
Antimicrobial Activity
7%
Immunopotentiation
7%
Mupirocin
7%
Pseudomonas aeruginosa
7%
Rat Model
7%
Acinetobacter Baumannii
7%
Precursor
7%
Enterobacterales
7%
Pharmacodynamics
7%
Secretory Immunoglobulin
7%
Lymph Node
7%
Skin Structure
7%
Respiratory Syncytial Virus Infection
7%
Porcine Model
7%
Membrane Transport Protein
7%